Clinical ProtocolsIn Situ HybridizationIn Situ Hybridization, FluorescenceCarcinoma in SituPrimed In Situ LabelingTime FactorsTreatment OutcomeResearch DesignRNA, MessengerReproducibility of ResultsPolymerase Chain ReactionImmunohistochemistryMolecular Sequence DataSensitivity and SpecificityAntineoplastic Combined Chemotherapy ProtocolsKeratomileusis, Laser In SituProspective StudiesNucleic Acid HybridizationBase SequenceRetrospective StudiesCarcinoma, Intraductal, NoninfiltratingRNA ProbesPregnancyWireless TechnologyFeasibility StudiesFollow-Up StudiesGene ExpressionDNA ProbesPilot ProjectsBreast NeoplasmsAlgorithmsTissue FixationReverse Transcriptase Polymerase Chain ReactionAmino Acid SequenceDigoxigeninStaining and LabelingCells, CulturedRats, Sprague-DawleyBrainDNA PrimersOvulation InductionSingle-Blind MethodIn Situ Nick-End LabelingDNASequence Analysis, DNAPatient SelectionBiopsyCryopreservationMice, Inbred C57BLImage Processing, Computer-AssistedCloning, MolecularPrognosisGonadotropin-Releasing HormoneComputer Communication NetworksParaffin EmbeddingCombined Modality TherapyInsemination, ArtificialCattleAnalysis of VarianceMagnetic Resonance ImagingTissue DistributionSpecimen HandlingGene AmplificationPredictive Value of TestsDNA, ComplementaryCell Culture TechniquesAntineoplastic ProtocolsDisease Models, AnimalChromosome AberrationsDose-Response Relationship, DrugKaryotypingGene Expression Regulation, DevelopmentalGene Expression ProfilingBenchmarkingMuscle, SkeletalCarcinoma, Ductal, BreastPregnancy RateRats, WistarDouble-Blind MethodEquipment DesignFlow CytometryOligonucleotide ProbesChromosome MappingBlotting, NorthernDrug Administration ScheduleQuality ControlCell DifferentiationFluorescent DyesFertilization in VitroTomography, X-Ray ComputedTherapy, Computer-AssistedCell LineRisk FactorsProteinsCost-Benefit AnalysisRadiation DosagePractice Guidelines as TopicClinical Trials as TopicMicroscopy, FluorescenceModels, Biological